Alethia Young Ptc Therapeutics, Inc. (PTCT) insider trading activity

Alethia Young is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 21,067 shares of PTCT, which is worth approximately $1.59 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K

23.44% 3M change

23.44% 12M change

Total Value Held $1.59 Million

Alethia Young Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	4,000 Added 15.96%	21,067 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	4,000 Added 18.99%	17,067 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	4,000 Added 23.44%	13,067 Common Stock
Sep 06 2023	SELL Open market or private sale	$464,890 $39.85 p/Share	11,666 Reduced 56.27%	9,067 Common Stock
Sep 06 2023	BUY Exercise of conversion of derivative security	$324,898 $27.85 p/Share	11,666 Added 45.93%	13,733 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	4,000 Added 30.61%	9,067 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	5,067 Added 50.0%	5,067 Common Stock

Also insider at

GRPH

Graphite Bio, Inc. Healthcare

Chief Financial Officer

BCYC

BICYCLE THERAPEUTICS plc Healthcare

Chief Financial Officer

PCRX

Pacira BioSciences, Inc. Healthcare

Director

Alethia Young

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account